Stay updated on Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Recruitment status on the study page has been updated to indicate that no participants are being sought. New help/guide sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment label was adjusted along with a revision notice (Revision: v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-13T04:39:14.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The revision label now shows v3.5.5, replacing the previous v3.5.4. This signals that the page has been updated to a newer version.
    Difference
    0.0%
    Check dated 2026-06-05T21:43:28.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, signaling a new version of the page. This appears to be a minor administrative update rather than a change to the study details or outcomes.
    Difference
    0.1%
    Check dated 2026-05-15T06:53:14.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page reflects a minor update to the platform/UI release revision, moving from “Revision: v3.5.2” to “Revision: v3.5.3.” This represents a technical/version change rather than a change to the displayed study information.
    Difference
    0.0%
    Check dated 2026-04-24T06:32:47.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2 and the v3.5.0 revision was removed.
    Difference
    0.0%
    Check dated 2026-04-17T02:47:33.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed, indicating an update to the page’s revision history.
    Difference
    0.0%
    Check dated 2026-03-19T06:24:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial page.